BWS
IOVA icon

Buck Wealth Strategies’s Iovance Biotherapeutics IOVA Stock Holding History

Buck Wealth Strategies’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125 Buy
+30
New +$114 ﹤0.01% 1130

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Buck Wealth Strategies's IOVA Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 30 shares worth $125. The stake represents ﹤0.01% of the portfolio and ranks #1130 among its holdings.

118 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Buck Wealth Strategies held 30 shares of Iovance Biotherapeutics worth $125 as of Q2 2026.
  • Iovance Biotherapeutics was a new Buck Wealth Strategies position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1130 holding.
  • 118 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.